• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

转移性癌细胞侵袭对肌球蛋白轻链激酶催化的肌球蛋白调节轻链磷酸化的依赖性。

Dependence of metastatic cancer cell invasion on MLCK-catalyzed phosphorylation of myosin regulatory light chain.

作者信息

Tohtong R, Phattarasakul K, Jiraviriyakul A, Sutthiphongchai T

机构信息

Department of Biochemistry, Faculty of Science, Mahidol University, Phya Thai, Bangkok, Thailand.

出版信息

Prostate Cancer Prostatic Dis. 2003;6(3):212-6. doi: 10.1038/sj.pcan.4500663.

DOI:10.1038/sj.pcan.4500663
PMID:12970723
Abstract

The role of myosin phosphorylation by myosin light chain kinase (MLCK) in regulating the invasiveness of metastatic cancer cells was investigated using the Dunning rat prostatic adenocarcinoma cell line, Mat Ly Lu, and in vitro invasion assay. Treatment with MLCK inhibitors resulted in marked reduction of invasiveness, which was principally due to impaired cellular motility, whereas the ability to survive and proliferate, to adhere to matrix, and to secrete gelatinases were minimally affected.

摘要

利用Dunning大鼠前列腺腺癌细胞系Mat Ly Lu和体外侵袭试验,研究了肌球蛋白轻链激酶(MLCK)介导的肌球蛋白磷酸化在调节转移性癌细胞侵袭性中的作用。用MLCK抑制剂处理导致侵袭性显著降低,这主要是由于细胞运动能力受损,而细胞存活、增殖、黏附于基质以及分泌明胶酶的能力受影响较小。

相似文献

1
Dependence of metastatic cancer cell invasion on MLCK-catalyzed phosphorylation of myosin regulatory light chain.转移性癌细胞侵袭对肌球蛋白轻链激酶催化的肌球蛋白调节轻链磷酸化的依赖性。
Prostate Cancer Prostatic Dis. 2003;6(3):212-6. doi: 10.1038/sj.pcan.4500663.
2
Inhibiting myosin light chain kinase retards the growth of mammary and prostate cancer cells.抑制肌球蛋白轻链激酶可延缓乳腺癌和前列腺癌细胞的生长。
Eur J Cancer. 2006 May;42(7):948-57. doi: 10.1016/j.ejca.2005.12.017. Epub 2006 Mar 30.
3
Glioma migration can be blocked by nontoxic inhibitors of myosin II.胶质瘤的迁移可被肌球蛋白II的无毒抑制剂阻断。
Cancer Res. 1999 May 1;59(9):2076-82.
4
In vivo phosphorylation of regulatory light chain of myosin II in sea urchin eggs and its role in controlling myosin localization and function during cytokinesis.海胆卵中肌球蛋白II调节性轻链的体内磷酸化及其在细胞分裂过程中控制肌球蛋白定位和功能的作用。
Cell Motil Cytoskeleton. 2008 Feb;65(2):100-15. doi: 10.1002/cm.20246.
5
PD98059-inhibited invasion of Dunning rat prostate cancer cells involves suppression of motility but not MMP-2 or uPA secretion.PD98059抑制邓宁大鼠前列腺癌细胞的侵袭,这涉及对细胞运动性的抑制,但不涉及MMP-2或尿激酶型纤溶酶原激活剂(uPA)的分泌抑制。
Oncol Rep. 2006 Jun;15(6):1605-10.
6
Key role of myosin light chain (MLC) kinase-mediated MLC2a phosphorylation in the alpha 1-adrenergic positive inotropic effect in human atrium.肌球蛋白轻链(MLC)激酶介导的MLC2a磷酸化在人心房α1-肾上腺素能正性肌力作用中的关键作用。
Cardiovasc Res. 2005 Jan 1;65(1):211-20. doi: 10.1016/j.cardiores.2004.09.019.
7
Inhibitory effect of phosphorylated myosin light chain kinase on the ATP-dependent actin-myosin interaction.磷酸化肌球蛋白轻链激酶对ATP依赖性肌动蛋白-肌球蛋白相互作用的抑制作用。
Biochem Biophys Res Commun. 1999 Jul 22;261(1):95-9. doi: 10.1006/bbrc.1999.0956.
8
The characterization of Ca(2+)-calmodulin independent phosphorylation of myosin light chains by a fragment from myosin light chain kinase.肌球蛋白轻链激酶片段对肌球蛋白轻链的钙(2+)-钙调蛋白非依赖性磷酸化的表征
Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai). 2003 Sep;35(9):793-800.
9
Inhibition of the myosin light chain kinase prevents hypoxia-induced blood-brain barrier disruption.抑制肌球蛋白轻链激酶可防止缺氧诱导的血脑屏障破坏。
J Neurochem. 2007 Jul;102(2):501-7. doi: 10.1111/j.1471-4159.2007.04506.x. Epub 2007 Apr 10.
10
Role of Rho, Rac, and Rho-kinase in phosphorylation of myosin light chain, development of polarity, and spontaneous migration of Walker 256 carcinosarcoma cells.Rho、Rac和Rho激酶在沃克256癌肉瘤细胞肌球蛋白轻链磷酸化、极性形成及自发迁移中的作用
Exp Cell Res. 2005 Aug 15;308(2):422-38. doi: 10.1016/j.yexcr.2005.05.001.

引用本文的文献

1
MLC2: Physiological Functions and Potential Roles in Tumorigenesis.肌球蛋白轻链2:生理功能及在肿瘤发生中的潜在作用
Cell Biochem Biophys. 2025 Mar 16. doi: 10.1007/s12013-025-01721-6.
2
Inhibition of MLCK‑mediated migration and invasion in human endometriosis stromal cells by NF‑κB inhibitor DHMEQ.NF-κB 抑制剂 DHMEQ 抑制人子宫内膜异位症基质细胞中 MLCK 介导的迁移和侵袭。
Mol Med Rep. 2023 Aug;28(2). doi: 10.3892/mmr.2023.13028. Epub 2023 Jun 16.
3
Myosin Light-Chain Kinase Inhibition Potentiates the Antitumor Effects of Avapritinib in PDGFRA D842V-Mutant Gastrointestinal Stromal Tumor.
肌球蛋白轻链激酶抑制增强了 Avapritinib 在 PDGFRA D842V 突变胃肠间质瘤中的抗肿瘤作用。
Clin Cancer Res. 2023 Jun 1;29(11):2144-2157. doi: 10.1158/1078-0432.CCR-22-0533.
4
A Drug Screening Reveals Minocycline Hydrochloride as a Therapeutic Option to Prevent Breast Cancer Cells Extravasation across the Blood-Brain Barrier.一项药物筛选显示盐酸米诺环素是预防乳腺癌细胞穿越血脑屏障外渗的一种治疗选择。
Biomedicines. 2022 Aug 16;10(8):1988. doi: 10.3390/biomedicines10081988.
5
Picturing Breast Cancer Brain Metastasis Development to Unravel Molecular Players and Cellular Crosstalk.描绘乳腺癌脑转移的发展以揭示分子参与者和细胞间相互作用。
Cancers (Basel). 2021 Feb 22;13(4):910. doi: 10.3390/cancers13040910.
6
Blockade of ROCK inhibits migration of human primary keratinocytes and malignant epithelial skin cells by regulating actomyosin contractility.ROCK 阻断通过调节肌动球蛋白收缩抑制人原代角质形成细胞和恶性上皮皮肤细胞的迁移。
Sci Rep. 2019 Dec 27;9(1):19930. doi: 10.1038/s41598-019-56447-2.
7
Quantitative Analysis of Seven New Prostate Cancer Biomarkers and the Potential Future of the 'Biomarker Laboratory'.七种新型前列腺癌生物标志物的定量分析及“生物标志物实验室”的潜在未来
Diagnostics (Basel). 2018 Jul 27;8(3):49. doi: 10.3390/diagnostics8030049.
8
Comparison of miRNA and gene expression profiles between metastatic and primary prostate cancer.转移性前列腺癌与原发性前列腺癌之间miRNA和基因表达谱的比较。
Oncol Lett. 2017 Nov;14(5):6085-6090. doi: 10.3892/ol.2017.6969. Epub 2017 Sep 15.
9
Migrastatics-Anti-metastatic and Anti-invasion Drugs: Promises and Challenges.迁移抑制剂——抗转移和抗侵袭药物:前景与挑战
Trends Cancer. 2017 Jun;3(6):391-406. doi: 10.1016/j.trecan.2017.04.008.
10
Myosin Light Chain Kinase: A Potential Target for Treatment of Inflammatory Diseases.肌球蛋白轻链激酶:治疗炎症性疾病的潜在靶点。
Front Pharmacol. 2017 May 23;8:292. doi: 10.3389/fphar.2017.00292. eCollection 2017.